FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2786500604> ?p ?o ?g. }

• W2786500604 abstract "Abstract Background Post-neurosurgical intracranial infections caused by multidrug-resistant or extensively drug-resistant Acinetobacter baumannii are difficult to treat and associated with high mortality. In this study, we analyzed the therapeutic efficacy of intravenous combined with intrathecal/intracerebral ventricle injection of polymyxin B for this type of intracranial infection. Methods This retrospective study was conducted from January 2013 to September 2017 at the Second Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou,China) and included 61 cases for which cerebrospinal fluid (CSF) cultures were positive for multidrug-resistant or extensively drug-resistant A. baumannii after a neurosurgical operation. Patients treated with intravenous and intrathecal/intracerebral ventricle injection of polymyxin B were assigned to the intrathecal/intracerebral group, and patients treated with other antibiotics without intrathecal/intracerebral injection were assigned to the intravenous group. Data for general information, treatment history, and the results of routine tests and biochemistry indicators in CSF, clinical efficiency, microbiological clearance rate, and the 28-day mortality were collected and analyzed. Results The rate of multidrug-resistant or extensively drug-resistant A. baumannii infection among patients who experienced an intracranial infection after a neurosurgical operation was 33.64% in our hospital. The isolated A. baumannii were resistant to various antibiotics, and most seriously to carbapenems (100.00% resistance rate to imipenem and meropenem), cephalosporins (resistance rates of 98.38% to cefazolin, 100.00% to ceftazidime, 100.00% to cefatriaxone, and 98.39% to cefepime). However, the isolated A. baumannii were completely sensitive to polymyxin B (sensitivity rate of 100.00%), followed by tigecycline (60.66%) and amikacin (49.18%). No significant differences in basic clinical data were observed between the two groups. Compared with the intravenous group, the intrathecal/intracerebral group had a significantly lower 28-day mortality (55.26% vs. 8.70%, P = 0.01) and higher rates of clinical efficacy and microbiological clearance (95.65% vs. 23.68%, P < 0.001; 91.30% vs. 18.42%, P < 0.001, respectively). Conclusions Intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B is an effective regimen for treating intracranial infections caused by multidrug-resistant or extensively drug-resistant A. baumannii." @default.
• W2786500604 created "2018-02-23" @default.
• W2786500604 creator A5003329837 @default.
• W2786500604 creator A5006498812 @default.
• W2786500604 creator A5022911304 @default.
• W2786500604 creator A5027475930 @default.
• W2786500604 creator A5049360744 @default.
• W2786500604 creator A5060026862 @default.
• W2786500604 creator A5062723211 @default.
• W2786500604 creator A5068461836 @default.
• W2786500604 date "2018-01-19" @default.
• W2786500604 modified "2023-10-16" @default.
• W2786500604 title "Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study" @default.
• W2786500604 cites W1606524132 @default.
• W2786500604 cites W1818889778 @default.
• W2786500604 cites W1909232415 @default.
• W2786500604 cites W1973310829 @default.
• W2786500604 cites W1978057383 @default.
• W2786500604 cites W1999768353 @default.
• W2786500604 cites W2001792911 @default.
• W2786500604 cites W2003756489 @default.
• W2786500604 cites W2004618470 @default.
• W2786500604 cites W2024720792 @default.
• W2786500604 cites W2026274122 @default.
• W2786500604 cites W2026278720 @default.
• W2786500604 cites W2051892672 @default.
• W2786500604 cites W2052130550 @default.
• W2786500604 cites W2058603740 @default.
• W2786500604 cites W2063062711 @default.
• W2786500604 cites W2070234836 @default.
• W2786500604 cites W2097399590 @default.
• W2786500604 cites W2110256580 @default.
• W2786500604 cites W2113749492 @default.
• W2786500604 cites W2142343447 @default.
• W2786500604 cites W2150055993 @default.
• W2786500604 cites W2159435953 @default.
• W2786500604 cites W2160312473 @default.
• W2786500604 cites W2162745520 @default.
• W2786500604 cites W2167117360 @default.
• W2786500604 cites W2168319665 @default.
• W2786500604 cites W2170001997 @default.
• W2786500604 cites W2171632431 @default.
• W2786500604 cites W2302009090 @default.
• W2786500604 cites W2305526013 @default.
• W2786500604 cites W2334914963 @default.
• W2786500604 cites W2561414729 @default.
• W2786500604 cites W2588163058 @default.
• W2786500604 cites W2736706750 @default.
• W2786500604 cites W2737664631 @default.
• W2786500604 doi "https://doi.org/10.1186/s13756-018-0305-5" @default.
• W2786500604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6330455" @default.
• W2786500604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30651977" @default.
• W2786500604 hasPublicationYear "2018" @default.
• W2786500604 type Work @default.
• W2786500604 sameAs 2786500604 @default.
• W2786500604 citedByCount "34" @default.
• W2786500604 countsByYear W27865006042019 @default.
• W2786500604 countsByYear W27865006042020 @default.
• W2786500604 countsByYear W27865006042021 @default.
• W2786500604 countsByYear W27865006042022 @default.
• W2786500604 countsByYear W27865006042023 @default.
• W2786500604 crossrefType "journal-article" @default.
• W2786500604 hasAuthorship W2786500604A5003329837 @default.
• W2786500604 hasAuthorship W2786500604A5006498812 @default.
• W2786500604 hasAuthorship W2786500604A5022911304 @default.
• W2786500604 hasAuthorship W2786500604A5027475930 @default.
• W2786500604 hasAuthorship W2786500604A5049360744 @default.
• W2786500604 hasAuthorship W2786500604A5060026862 @default.
• W2786500604 hasAuthorship W2786500604A5062723211 @default.
• W2786500604 hasAuthorship W2786500604A5068461836 @default.
• W2786500604 hasBestOaLocation W27865006041 @default.
• W2786500604 hasConcept C114851261 @default.
• W2786500604 hasConcept C126322002 @default.
• W2786500604 hasConcept C2776315533 @default.
• W2786500604 hasConcept C2777050379 @default.
• W2786500604 hasConcept C2777637488 @default.
• W2786500604 hasConcept C2779375183 @default.
• W2786500604 hasConcept C2779631663 @default.
• W2786500604 hasConcept C2780026444 @default.
• W2786500604 hasConcept C2780675486 @default.
• W2786500604 hasConcept C501593827 @default.
• W2786500604 hasConcept C523546767 @default.
• W2786500604 hasConcept C54355233 @default.
• W2786500604 hasConcept C71924100 @default.
• W2786500604 hasConcept C86803240 @default.
• W2786500604 hasConcept C89423630 @default.
• W2786500604 hasConcept C94665300 @default.
• W2786500604 hasConceptScore W2786500604C114851261 @default.
• W2786500604 hasConceptScore W2786500604C126322002 @default.
• W2786500604 hasConceptScore W2786500604C2776315533 @default.
• W2786500604 hasConceptScore W2786500604C2777050379 @default.
• W2786500604 hasConceptScore W2786500604C2777637488 @default.
• W2786500604 hasConceptScore W2786500604C2779375183 @default.
• W2786500604 hasConceptScore W2786500604C2779631663 @default.
• W2786500604 hasConceptScore W2786500604C2780026444 @default.
• W2786500604 hasConceptScore W2786500604C2780675486 @default.
• W2786500604 hasConceptScore W2786500604C501593827 @default.
• W2786500604 hasConceptScore W2786500604C523546767 @default.
• W2786500604 hasConceptScore W2786500604C54355233 @default.
• W2786500604 hasConceptScore W2786500604C71924100 @default.

• next